Co-Diagnostics, Inc. - 10-Q Filing
Co-Diagnostics, Inc. reports Q3 fiscal 2026 results including new equity distribution agreements and private placement with Maxim Group LLC.
Tickers: $CODX
Co-Diagnostics, Inc. reports Q3 fiscal 2026 results including new equity distribution agreements and private placement with Maxim Group LLC.
Tickers: $CODX